REMLIFETrading & Distributors
Remedium Lifecare Ltd — Profit & Loss Statement
₹0.36
+0.00%
Remedium Lifecare Ltd Profit & Loss Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.00 | 70258.04 | -0.41 Cr | 30502.39 | — |
| Tax Rate For Calcs | 0.30 | 0.35 | 0.27 | 0.29 | — |
| Normalized EBITDA | 9.71 Cr | 54.51 Cr | 9.16 Cr | 1.77 Cr | — |
| Total Unusual Items | 0.00 | 0.02 Cr | -1.55 Cr | 0.01 Cr | — |
| Total Unusual Items Excluding Goodwill | 0.00 | 0.02 Cr | -1.55 Cr | 0.01 Cr | — |
| Net Income From Continuing Operation Net Minority Interest | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Reconciled Depreciation | 0.04 Cr | 0.06 Cr | 0.15 Cr | 0.07 Cr | — |
| Reconciled Cost Of Revenue | 398.14 Cr | 4.00K Cr | 493.86 Cr | 498.48 Cr | — |
| EBITDA | 9.71 Cr | 54.53 Cr | 7.62 Cr | 1.78 Cr | — |
| EBIT | 9.67 Cr | 54.48 Cr | 7.47 Cr | 1.70 Cr | — |
| Net Interest Income | -5.29 Cr | -4.78 Cr | -0.45 Cr | -0.23 Cr | — |
| Interest Expense | 5.29 Cr | 4.02 Cr | 0.07 Cr | 0.18 Cr | — |
| Normalized Income | 2.13 Cr | 32.72 Cr | 6.56 Cr | 1.07 Cr | — |
| Net Income From Continuing And Discontinued Operation | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Total Expenses | 406.38 Cr | 4.01K Cr | 501.27 Cr | 503.05 Cr | — |
| Diluted Average Shares | 61.01 Cr | 57.77 Cr | 2.06 Cr | 57.77 Cr | — |
| Basic Average Shares | 61.01 Cr | 57.77 Cr | 2.06 Cr | 57.77 Cr | — |
| Diluted EPS | 0.03 | 0.57 | 2.63 | 0.02 | — |
| Basic EPS | 0.03 | 0.57 | 2.63 | 0.02 | — |
| Diluted NI Availto Com Stockholders | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Net Income Common Stockholders | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Net Income Including Noncontrolling Interests | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Net Income Discontinuous Operations | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Net Income Continuous Operations | 2.13 Cr | 32.73 Cr | 5.43 Cr | 1.08 Cr | — |
| Tax Provision | 2.25 Cr | 17.72 Cr | 1.97 Cr | 0.45 Cr | — |
| Pretax Income | 4.38 Cr | 50.45 Cr | 7.40 Cr | 1.53 Cr | — |
| Other Non Operating Income Expenses | 10.80 Cr | 21.08 Cr | — | — | 20000.00 |
| Special Income Charges | 0.00 | 0.02 Cr | -1.55 Cr | 0.01 Cr | — |
| Net Non Operating Interest Income Expense | -5.29 Cr | -4.78 Cr | -0.45 Cr | -0.23 Cr | — |
| Interest Expense Non Operating | 5.29 Cr | 4.02 Cr | 0.07 Cr | 0.18 Cr | — |
| Operating Income | -1.13 Cr | 34.15 Cr | 8.57 Cr | 1.74 Cr | — |
| Operating Expense | 8.25 Cr | 6.18 Cr | 7.41 Cr | 4.57 Cr | — |
| Other Operating Expenses | 7.45 Cr | 2.96 Cr | 1.97 Cr | 2.34 Cr | — |
| Depreciation And Amortization In Income Statement | 0.04 Cr | 0.06 Cr | 0.15 Cr | 0.07 Cr | — |
| Depreciation Income Statement | 0.04 Cr | 0.06 Cr | 0.15 Cr | 0.07 Cr | — |
| Gross Profit | 7.12 Cr | 40.33 Cr | 15.98 Cr | 6.31 Cr | — |
| Cost Of Revenue | 398.14 Cr | 4.00K Cr | 493.86 Cr | 498.48 Cr | — |
| Total Revenue | 405.25 Cr | 4.04K Cr | 509.84 Cr | 504.79 Cr | — |
| Operating Revenue | 405.25 Cr | 4.04K Cr | 509.84 Cr | 504.79 Cr | — |
| Interest Income | — | 0.00 | 0.08 Cr | 0.00 | 0.00 |
| Rent Expense Supplemental | — | 1.00 Cr | 0.61 Cr | 0.34 Cr | 0.38 Cr |
| Write Off | — | -0.02 Cr | 1.55 Cr | -0.01 Cr | -8000.00 |
| Total Other Finance Cost | — | 0.76 Cr | 0.45 Cr | 0.05 Cr | 42000.00 |
| Interest Income Non Operating | — | 0.00 | 0.08 Cr | 0.00 | 0.00 |
| Selling General And Administration | — | 1.23 Cr | 3.68 Cr | 1.27 Cr | 0.53 Cr |
| Selling And Marketing Expense | — | 0.30 Cr | 0.03 Cr | 0.24 Cr | 0.04 Cr |
| General And Administrative Expense | — | 0.93 Cr | 3.65 Cr | 1.03 Cr | 0.49 Cr |
| Rent And Landing Fees | — | 1.00 Cr | 0.61 Cr | 0.34 Cr | 0.28 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Remedium Lifecare Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.